| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.00021 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.00022 | 1 |